Renasant Bank’s Medpace MEDP Stock Holding History

Renasant Bank’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$206K	Hold	428	–	–	0.15%	135
2025 Q4	$240K	Sell	428 -19	-4%	-$10.8K	0.16%	126
2025 Q3	$230K	Buy	+447	New	+$195K	0.15%	134

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Renasant Bank's MEDP Position: Q1 2026 in Review

Renasant Bank held its Medpace (MEDP) position steady in Q1 2026 at 428 shares worth $206K. The position accounts for 0.15% of the portfolio, ranked #135.

Renasant Bank first reported a position in MEDP in Q3 2025 and has held it in 3 quarters since. The position peaked at $240K in Q4 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

Renasant Bank held 428 shares of Medpace worth $206K as of Q1 2026.
Renasant Bank left its Medpace share count unchanged in Q1 2026.
Medpace made up 0.15% of Renasant Bank's portfolio in Q1 2026, its #135 holding.
Renasant Bank first reported a position in Medpace in Q3 2025 and has held it in 3 quarters since.
Renasant Bank's Medpace position peaked at $240K in Q4 2025.
729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Renasant Bank's 13F filing for Q1 2026, filed 29 Apr 2026.